Resources: Page 286

FDG-PET/MRI study breaks ground in rare inflammatory condition
By Wayne Forrest
Wednesday, December 2 | 3:10 p.m.-3:20 p.m. | SSM14-02 | Room S504CDAnother group from Germany is reporting promising results of FDG-PET/MRI for idiopathic retroperitoneal fibrosis, a rare inflammatory condition in which a fibrotic mass surrounds the abdominal aorta and can cause severe complications, such as renal failure.
November 11, 2015
Bone mets no match for hybrid 3D hot-spot analysis of PET/CT
By Eric Barnes
Wednesday, December 2 | 12:45 p.m.-1:15 p.m.| NM223-SD-WEB11 | Room S503ABA technique that identifies bone metastasis "hot spots" automatically from PET/CT could vastly improve radiologists' ability to diagnose and follow-up patients with bone cancer.
November 11, 2015
PET/MRI lends a hand in challenging cervical cancer cases
By Wayne Forrest
Wednesday, December 2 | 10:40 a.m.-10:50 a.m. | SSK14-02 | Room N229A new German study has added to the evidence that PET/MRI can be a valuable resource in oncology applications, especially in difficult-to-diagnose cases.
November 11, 2015
Mayo Clinic study shows advantages of MBI
By Wayne Forrest
Tuesday, December 1 | 3:40 p.m.-3:50 p.m. | SSJ02-05 | Room E450AResearchers from the Mayo Clinic in Rochester, MN, have concluded that molecular breast imaging (MBI) may be a better option than breast-specific gamma imaging, especially for low-dose breast imaging.
November 11, 2015
PEM device receives kudos from Dutch researchers
By Wayne Forrest
Tuesday, December 1 | 3:10 p.m.-3:20 p.m. | SSJ02-02 | Room E450AA Spanish company's positron emission mammography (PEM) system is drawing positive reviews from Dutch researchers, who will share their thoughts in this afternoon session.
November 11, 2015
Study explores PET/CT parameters to predict NSCLC outcomes
By Wayne Forrest
Tuesday, December 1 | 3:00 p.m.-3:10 p.m. | SSJ17-01 | Room S505ABPretreatment volumetric PET/CT parameters, such as metabolic tumor volume and total lesion glycolysis, are strong predictors of overall survival for patients with non-small cell lung cancer (NSCLC), according to this study to be presented on Tuesday afternoon.
November 11, 2015
Ga-68 PSMA PET/CT proves valuable for prostate cancer
By Wayne Forrest
Tuesday, December 1 | 3:00 p.m.-3:10 p.m. | SSJ14-01 | Room S504CDGallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) PET/CT is accurate for staging and restaging patients with prostate cancer, according to this paper from Mumbai, India.
November 11, 2015
FDG-PET/MRI enhances breast cancer diagnosis and staging
By Wayne Forrest
Tuesday, December 1 | 3:00 p.m.-3:10 p.m. | SSJ02-01 | Room E450AMultiparameter FDG-PET/MRI can improve the specificity of dynamic contrast-enhanced MRI, which could lead to more-accurate staging of breast lesions and fewer false positives and unnecessary biopsies.
November 11, 2015
Whole-body PET/MRI equals PET/CT for focal bone lesion detection
By Wayne Forrest
Tuesday, December 1 | 11:40 a.m.-11:50 a.m. | SSG11-08 | Room S505ABIn this Tuesday session, a group from Washington University in St. Louis will detail the efficacy of whole-body PET/MRI for detecting FDG-avid focal bone lesions.
November 11, 2015
NaF-FDG-PET/MRI tops bone scintigraphy for skeletal disease
By Wayne Forrest
Tuesday, December 1 | 11:40 a.m.-11:50 a.m. | SSG09-08 | Room S504CDPET/MRI with sodium fluoride (NaF) and FDG is superior to bone scintigraphy for evaluating skeletal disease, according to this study from U.S. researchers.
November 11, 2015
FDG-PET/MRI with DWI advances lymphoma diagnosis
By Wayne Forrest
Tuesday, December 1 | 11:30 a.m.-11:40 a.m. | SSG11-07 | Room S505ABFDG-PET/MRI with diffusion-weighted imaging (DWI) shows greater diagnostic value for lymphoma than FDG-PET/CT, while delivering less radiation, according to this study from the Medical University of Vienna.
November 11, 2015
FDG-PET/MRI bests DWI-MRI for lymphoma
By Wayne Forrest
Tuesday, December 1 | 11:20 a.m.-11:30 a.m. | SSG11-06 | Room S505ABIn another study led by Dr. Johannes Grueneisen from University Hospital Essen, researchers found that FDG-PET/MRI was better than diffusion-weighted MRI (DWI-MRI) alone for detecting malignant and benign lesions in lymphoma patients.
November 11, 2015
Previous Page
Page 286 of 725
Next Page